1. |
Drescher U. Eph family functions from an evolutionary perspective. Curr Opin Genet Dev, 2002, 12(4): 397-402.
|
2. |
Suetterlin P, Marler KM, Drescher U. Axonal ephrinA/EphA interactions, and the emergence of order in topographic projections. Semin Cell Dev Biol, 2012, 23(1): 1-6.
|
3. |
Kamat AA, Coffey D, Merritt WM, et al. EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer. Cancer, 2009, 115(12): 2684-2692.
|
4. |
Zeng G, Hu Z, Kinch MS, et al. High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia. Am J Pathol, 2003, 163(6): 2271-2276.
|
5. |
吕西, 李徐生, 张有成, 等. EphA2 mRNA 和 VEGF 在肝癌细胞中的表达及其关系. 中华肝胆外科杂志, 2006, 12(10): 680-683.
|
6. |
蒋学风, 唐琼兰, 何欣欣, 等. EphA2 及其配体在子宫内膜样腺癌中的表达及其血管生成的关系. 中国病理生理杂志, 2013, 29(5): 857-861.
|
7. |
蒋萍, 李景和, 罗庚求, 等. EphA2 对结肠癌细胞株 HCT116 中 VEGF 和 MMP9 蛋白表达的影响. 中南大学学报(医学版), 2007, 32(4): 679-683.
|
8. |
Aasheim HC, Patzke S, Hjorthaug HS, et al. Characterization of a novel Eph receptor tyrosine kinase, EphA10, expressed in testis. Biochim Biophys Acta, 2005, 1723(1-3): 1-7.
|
9. |
O’Leary DD, Wilkinson DG. Eph receptors and ephrins in neural development. Curr Opin Neurobiol, 1999, 9(1): 65-73.
|
10. |
Sasaki E, Hikono H, Kaku Y, et al. ephA9, a novel avian receptor tyrosine kinase gene. Gene, 2003, 316: 103-110.
|
11. |
赵玉斌, 张少华, 张积仁, 等. ER、PR 和 EphA2 在乳腺癌中的表达及临床意义. 实用肿瘤杂志, 2010, 25(1): 41-44.
|
12. |
Nakamoto M. Eph receptors and ephrins. Int J Biochem Cell Biol, 2000, 32(1): 7-12.
|
13. |
Tandon M, Vemula SV, Mittal SK. Emerging strategies for EphA2 receptor targeting for cancer therapeutics. Expert Opin Ther Targets, 2011, 15(1): 31-51.
|
14. |
Zelinski DP, Zantek ND, Stewart JC, et al. EphA2 overexpression causes tumorigenesis of mammary epithelial cells. Cancer Res, 2001, 61(5): 2301-2306.
|
15. |
Fang WB, Brantley-Sieders DM, Parker MA, et al. A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis. Oncogene, 2005, 24(53): 7859-7868.
|
16. |
Thaker PH, Deavers M, Celestino J, et al. EphA2 expression is associated with aggressive features in ovarian carcinoma. Clin Cancer Res, 2004, 10(15): 5145-5150.
|
17. |
Choi K, Creighton CJ, Stivers D, et al. Transcriptional profiling of non-small cell lung cancer cells with activating EGFR somatic mutations. PLoS One, 2007, 2(11): e1226.
|
18. |
韩丽萍, 董子明, 乔玉环, 等. 卵巢癌组织中 EphA2 受体蛋白的表达. 郑州大学学报(医学版), 2005, 40(2): 308-311.
|
19. |
Kaenel P, Mosimann M, Andres AC. The multifaceted roles of Eph/ephrin signaling in breast cancer. Cell Adh Migr, 2012, 6(2): 138-147.
|
20. |
Brantley-Sieders DM, Fang WB, Hwang Y, et al. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice. Cancer Res, 2006, 66(21): 10315-10324..
|
21. |
Merritt WM, Kamat AA, Hwang JY, et al. Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer. Cancer Biol Ther, 2010, 10(12): 1306-1314..
|
22. |
Valladares A, Hernández NG, Gómez FS, et al. Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women. Cancer Genet Cytogenet, 2006, 170(2): 147-151.
|
23. |
Herrem CJ, Tatsumi T, Olson KS, et al. Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma. Clin Cancer Res, 2005, 11(1): 226-231.
|
24. |
Huang J, Xiao D, Li G,et al. EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells. Oncogene, 2014, 33(21): 2737-2747.
|
25. |
Miyazaki K, Inokuchi M, Takagi Y, et al. EphA4 is a prognostic factor in gastric cancer. BMC Clin Pathol, 2013, 13(1): 19.
|